C Lin

Founder & Chief Executive Officer (CEO) at Rare Genomics Institute | South San Francisco, California, United States

About C Lin

C. Jimmy Lin, MD, PhD, MHS, is a visionary leader in the field of genomics and personalized medicine, currently serving as the Founder and Chief Executive Officer (CEO) of Rare Genomics Institute. Under his leadership, the organization has pioneered innovative approaches to support patients with orphan diseases, leveraging a dedicated microfunding platform that connects individuals with leading academic scientists and commercial institutions. Dr. Lin's extensive expertise in molecular biology, bioinformatics, and computational biology informs the strategic direction of Rare Genomics, enabling the institute to facilitate personalized research projects that are tailored to the unique genetic profiles of patients.

At Rare Genomics, Dr. Lin is at the forefront of developing cutting-edge diagnostic technologies and research methodologies that aim to address the unmet needs of patients facing rare and complex conditions. His previous experience as Chief Scientific Officer at Natera, where he led oncology initiatives, has equipped him with a robust understanding of cancer genomics and the intricacies of biotechnology. This background allows him to effectively bridge the gap between scientific research and clinical application, ensuring that innovative solutions are accessible to those who need them most.

Dr. Lin's commitment to advancing the field of genomics is further exemplified by his ability to communicate complex scientific concepts to diverse audiences, making him a sought-after speaker at industry conferences. His passion for research and dedication to improving patient outcomes continue to drive the mission of Rare Genomics Institute, as he works tirelessly to empower patients and foster collaboration among the scientific community.

C Lin Work